Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Heterologous prime-boost vaccination"'
Autor:
Noopur Bhatnagar, Ki-Hye Kim, Jeeva Subbiah, Sakinah Muhammad-Worsham, Bo Ryoung Park, Rong Liu, Phillip Grovenstein, Bao-Zhong Wang, Sang-Moo Kang
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1209 (2023)
With concerns about the efficacy of repeat annual influenza vaccination, it is important to better understand the impact of priming vaccine immunity and develop an effective vaccination strategy. Here, we determined the impact of heterologous prime-b
Externí odkaz:
https://doaj.org/article/31e1c05891a348caac930c57c05ae5d9
Autor:
Chong Li, Marie R. Culhane, Maxim Cheeran, Lucina Galina Pantoja, Micah L. Jansen, Deborah Amodie, Martha A. Mellencamp, Montserrat Torremorell
Publikováno v:
Veterinary Research, Vol 51, Iss 1, Pp 1-15 (2020)
Abstract Influenza A viruses evolve rapidly to escape host immunity. In swine, this viral evolution has resulted in the emergence of multiple H1 and H3 influenza A virus (IAV) lineages in the United States (US) pig populations. The heterologous prime
Externí odkaz:
https://doaj.org/article/c9d2cabfbe7a4510a3cce6a092a56e61
Autor:
Zsolt Matula, Márton Gönczi, Gabriella Bekő, Béla Kádár, Éva Ajzner, Ferenc Uher, István Vályi-Nagy
Publikováno v:
Vaccines, Vol 10, Iss 4, p 539 (2022)
In the present study, antibody and T cell-mediated immune responses elicited by BBIBP-CorV and BNT162b2 vaccines were compared 6 months after the two-dose immunization of healthy individuals. Additionally, antibody and T cell responses after the thir
Externí odkaz:
https://doaj.org/article/8817b0581e0f4732a443fadcb70036d9
Publikováno v:
Vaccines, Vol 10, Iss 2, p 322 (2022)
Within a year after the emergence of SARS-CoV-2, several vaccines had been developed, clinically evaluated, proven to be efficacious in preventing symptomatic disease, and licensed for global use. The remaining questions about the vaccines concern th
Externí odkaz:
https://doaj.org/article/1e0df9526ead4be2abe81dd0be6761bd
Autor:
Kang, Noopur Bhatnagar, Ki-Hye Kim, Jeeva Subbiah, Sakinah Muhammad-Worsham, Bo Ryoung Park, Rong Liu, Phillip Grovenstein, Bao-Zhong Wang, Sang-Moo
Publikováno v:
Vaccines; Volume 11; Issue 7; Pages: 1209
With concerns about the efficacy of repeat annual influenza vaccination, it is important to better understand the impact of priming vaccine immunity and develop an effective vaccination strategy. Here, we determined the impact of heterologous prime-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::be6901f5a49cc0e2ffc20d81225c3f88
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Journal of Cancer
A higher risk of death from coronavirus disease 19 has been shown for patients with solid cancers or haematological malignancies (HM). Thanks to the accelerated development of anti-SARS-SoV-2 vaccines in less than a year since the start of the global
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30fa1971af1cf282796da67288b70169
http://europepmc.org/articles/PMC8260097
http://europepmc.org/articles/PMC8260097
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
OncoImmunology, Vol 4, Iss 11 (2015)
Therapeutic cancer vaccines are an attractive alternative to conventional therapies for treating malignant tumors, and successful tumor eradication depends primarily on obtaining high numbers of long-lasting tumor-reactive CD8+ T cells. Dendritic cel
Externí odkaz:
https://doaj.org/article/869b1b5f73104f13aa2a3509b8dbc158